News Secretive Moderna could finally go public with $500m IPO RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.
Partner Content Partner Content New collaboration will advance human-based drug evaluation Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety
Partner Content Partner Content Overcoming bottlenecks in early drug discovery with the powe... Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry
News Amgen invests £50m in UK genetics firm Oxford Nanopore Biotech giant Amgen has ploughed £50 million into a genetic sequencing company to support the development of its cutting-edge technology.
News Crescendo hires ex-Roche R&D guru to develop T-cell technolo... Biotech has already raised $70m this year in second funding round
R&D UK regenerative medicine biotech appoints veteran 'drug hunt... Biotech aims to wake up stem cells with small molecules to repair damaged tissues
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.